gene disorder testing

Is Medicine a Big Data Problem?

By Ted Driscoll / March 21, 2014 / 0 Comments

Human beings are big data. We aren’t just 175 pounds of meat and bone. We aren’t just piles of hydrogen and carbon and oxygen. What makes us all different is how it’s all organized and that is information.
We can no longer treat people based on simple numbers like weight, pulse, blood pressure, and temperature. What makes us different is much more complicated than that.

Read More

Congratulations: Quest Diagnostics to offer access to Natera’s Panorama, non-invasive prenatal test

By Ted Driscoll / February 23, 2013 / 0 Comments

Congratulations to Natera—our portfolio company who is the leading innovator in prenatal genetic testing! Yesterday they announced a major deal with Quest Diagnostics (NYSE: DGX), the world’s leading diagnostic information services company. Quest Diagnostics will offer physicians access to Panorama™, the new non-invasive prenatal test developed by Natera. (Read the Quest Press Release) Panorama uses […]

Read More

Ted Driscoll featured in Pharmalot, Op-Ed: Entering The Golden Age Of Big Data

By Claremont Creek Alerts / February 23, 2013 / 0 Comments

February 20, 2013   source: the original post by Ed Silverman appeared in Pharmalot As drug development and diagnostics increasingly converge, the advent of personalized medicine is increasing all the time. Of course, we are not quite there yet, but the advent of electronic medical records and the genome are inching us closer all the time. But […]

Read More

Claremont Creek Ventures’ portfolio company Gene Security Network in race for prenatal test

By Claremont Creek Alerts / December 15, 2011 / 0 Comments

September 9, 2011  source: originally published in the San Francisco Business Times Gene Security Network’s race to develop safer, more accurate prenatal test is all business for Matt Rabinowitz — and it’s personal. A relative of Rabinowitz, Gene Security Network’s CEO, took a blood test for the likelihood of Down’s syndrome in her unborn baby and […]

Read More

Moving Quickly from an Idea to a Product

By Brad Webb / July 6, 2011 / 0 Comments

July 1, 2011  source: Genetic Engineering & Biotechnology News by Brad Webb Rapid Transition from Laboratory Discoveries to Commercialization Is Transforming Healthcare It’s been less than a decade since a full human genome was sequenced, but already there is talk that the promise of genomics-inspired personal medicine is not being realized. I couldn’t disagree more. […]

Read More

Gene Security Network Completes Funding to Expand Into New DNA Testing Markets

By Claremont Creek Alerts / November 3, 2010 / 1 Comment

November 1, 2010  source: Gene Security Network (download the pdf press release) REDWOOD CITY, CA – November 1, 2010 – Gene Security Network, Inc. (GSN) today announced the closing of its $12M Series C financing. The financing round was led by Sequoia Capital and included Claremont Creek Ventures, Founders Fund, and Lightspeed Venture Partners. GSN […]

Read More

Meet our team

Claremont Creek Ventures was founded in 2005 by Nat Goldhaber, John Steuart and Randy Hawks to pursue early stage investing in exceptional technology startups.

Nat_Boldhaber7718 -1200px

NAT GOLDHABER

Nat Goldhaber is a co-founder of Claremont Creek Ventures. 

TED DRISCOLL

Ted is an expert on digital health and diagnostics, from big data and health technology to genomics and personalized medicine.

Paul_Straub7765 -1200px

PAUL STRAUB

Paul is particularly focused on the potential of digital and business innovation to impact and advance broad-impact industries.

Brad_Webb8124 1200px crop

BRAD WEBB

Brad is focused on the role of genomics and biomarker data analytics in driving the next generation of diagnostics and drug development.

Randy_Hawks7690 -1200px

RANDY HAWKS

Randy Hawks is a co-founder of Claremont Creek Ventures.

Post Categories

Archives